Breast Implants and Reconstructive Devices | Market Insights | US | 2023
The cancelation or postponement of elective treatments, including breast augmentations and reconstructions, as a result of the COVID-19 pandemic and subsequent waves, had a short-term negative impact on the US market for breast implants and reconstructive devices. Following that, procedure volume increased as substantial percentages of the US population were vaccinated and restrictions were relaxed. Beyond the impact of pandemic, the market will be driven by favorable demographics, improved physician training, increased aesthetic consciousness, and overall marketing efforts from the major companies, as well as continued product innovation.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for breast implants and reconstructive devices in the US from 2019 through 2031.
